Maud Reymond

564 total citations
13 papers, 308 citations indexed

About

Maud Reymond is a scholar working on Genetics, Epidemiology and Surgery. According to data from OpenAlex, Maud Reymond has authored 13 papers receiving a total of 308 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Genetics, 9 papers in Epidemiology and 6 papers in Surgery. Recurrent topics in Maud Reymond's work include Inflammatory Bowel Disease (11 papers), Microscopic Colitis (6 papers) and Diagnosis and treatment of tuberculosis (4 papers). Maud Reymond is often cited by papers focused on Inflammatory Bowel Disease (11 papers), Microscopic Colitis (6 papers) and Diagnosis and treatment of tuberculosis (4 papers). Maud Reymond collaborates with scholars based in France. Maud Reymond's co-authors include Anthony Buisson, Bruno Pereira, Constance Hordonneau, Marion Goutte, Gilles Bommelaer, Michel Dapoigny, Félix Goutorbe, Olivier Y. Rouquette, Benoît Magnin and Clara Yzet and has published in prestigious journals such as Gastroenterology, Journal of Hepatology and Transplantation.

In The Last Decade

Maud Reymond

13 papers receiving 303 citations

Peers

Maud Reymond

GENET

EPIDE

SURGE

IMMUN

HEPAT

N. Scaglione Italy

Eric Froguel France

Sónia Bernardo Portugal

Lucas Guillo France

Félix Goutorbe France

Sunil Samuel United Kingdom

Hedia Brixi‐Benmansour France

Ana Rita Gonçalves Portugal

María Josefina Etchevers Spain

Joaquín Poza Cordón Spain

N. Scaglione Italy

Maud Reymond

284 ×1.1

GENET

225 ×0.9

EPIDE

125 ×1.0

SURGE

44 ×0.9

IMMUN

20 ×0.7

HEPAT

Citations per year, relative to Maud Reymond Maud Reymond (= 1×) peers N. Scaglione

Countries citing papers authored by Maud Reymond

Since Specialization

Citations

This map shows the geographic impact of Maud Reymond's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maud Reymond with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maud Reymond more than expected).

Fields of papers citing papers by Maud Reymond

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maud Reymond. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maud Reymond. The network helps show where Maud Reymond may publish in the future.

Co-authorship network of co-authors of Maud Reymond

This figure shows the co-authorship network connecting the top 25 collaborators of Maud Reymond. A scholar is included among the top collaborators of Maud Reymond based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maud Reymond. Maud Reymond is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Buisson, Anthony, Maud Reymond, Michel Dapoigny, et al.. (2022). Top-down Versus Step-up Strategies to Prevent Postoperative Recurrence in Crohn’s Disease. Inflammatory Bowel Diseases. 29(2). 185–194. 8 indexed citations

Buisson, Anthony, Maria Nachury, Maud Reymond, et al.. (2022). Effectiveness of Switching From Intravenous to Subcutaneous Infliximab in Patients With Inflammatory Bowel Diseases: the REMSWITCH Study. Clinical Gastroenterology and Hepatology. 21(9). 2338–2346.e3. 53 indexed citations

Buisson, Anthony, Maria Nachury, Maud Reymond, et al.. (2022). P400 Evolution of clinical and pharmacological parameters after switching from intra-venous to subcutaneous infliximab in patients with inflammatory bowel disease: the REMSWITCH study. Journal of Crohn s and Colitis. 16(Supplement_1). i393–i394. 4 indexed citations

Buisson, Anthony, Maria Nachury, Maud Reymond, et al.. (2022). 718: EVOLUTION OF CLINICAL AND PHARMACOLOGICAL PARAMETERS AFTER SWITCHING FROM INTRA-VENOUS TO SUBCUTANEOUS INFLIXIMAB IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE : THE REMSWITCH STUDY. Gastroenterology. 162(7). S–182. 2 indexed citations

Boschetti, Gilles, Bruno Pereira, Bernard Flourié, et al.. (2021). Comparison of short‐ and long‐term effectiveness between ustekinumab and vedolizumab in patients with Crohn's disease refractory to anti‐tumour necrosis factor therapy. Alimentary Pharmacology & Therapeutics. 53(12). 1289–1299. 33 indexed citations

Hordonneau, Constance, Michel Dapoigny, Maud Reymond, et al.. (2020). Transmural healing and MRI healing are associated with lower risk of bowel damage progression than endoscopic mucosal healing in Crohn’s disease. Alimentary Pharmacology & Therapeutics. 53(5). 577–586. 57 indexed citations

Hordonneau, Constance, Guillaume Bouguen, Félix Goutorbe, et al.. (2020). Early Transmural Response Assessed Using Magnetic Resonance Imaging Could Predict Sustained Clinical Remission and Prevent Bowel Damage in Patients with Crohn’s Disease Treated with Anti-Tumour Necrosis Factor Therapy. Journal of Crohn s and Colitis. 14(11). 1524–1534. 31 indexed citations

Buisson, Anthony, Constance Hordonneau, Félix Goutorbe, et al.. (2018). Bowel wall healing assessed using magnetic resonance imaging predicts sustained clinical remission and decreased risk of surgery in Crohn’s disease. Journal of Gastroenterology. 54(4). 312–320. 37 indexed citations

Abergel, Armand, C. Hézode, Tarik Asselah, et al.. (2018). High efficacy and safety of grazoprevir and elbasvir for 8 weeks in treatment-naive, non-severe fibrosis HCV GT1b-infected patients: Interim Results of the STREAGER Study. Journal of Hepatology. 68. S110–S110. 8 indexed citations

10.

Buisson, Anthony, Bruno Pereira, Marion Goutte, et al.. (2017). Magnetic resonance index of activity (MaRIA) and Clermont score are highly and equally effective MRI indices in detecting mucosal healing in Crohn’s disease. Digestive and Liver Disease. 49(11). 1211–1217. 50 indexed citations

11.

Reymond, Maud, Louise Barbier, Ephrem Salamé, et al.. (2017). Does Portopulmonary Hypertension Impede Liver Transplantation in Cirrhotic Patients? A French Multicentric Retrospective Study. Transplantation. 102(4). 616–622. 22 indexed citations

12.

Buisson, Anthony, Bruno Pereira, Marion Goutte, et al.. (2017). Magnetic Resonance Index of Activity (MaRIA) and Clermont Score are Two MRI Indices Which are Highly and Equally Effective in Detecting Mucosal Healing in Crohn’s Disease. Gastroenterology. 152(5). S210–S211. 2 indexed citations

13.

Lambert, Céline, Bruno Pereira, Marion Goutte, et al.. (2017). P572 Medical therapies for stricturing Crohn's disease: efficacy and cross-sectional imaging predictors of therapeutic failure. Journal of Crohn s and Colitis. 11(suppl_1). S371–S372. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact